<DOC>
	<DOCNO>NCT00180544</DOCNO>
	<brief_summary>The purpose study evaluate safety effectiveness RX HERCULINK 14 Peripheral Stent System treat atherosclerotic renal artery stenosis .</brief_summary>
	<brief_title>Safety Effectiveness Study HERCULINK 14 Stent Treat Renal Artery Disease</brief_title>
	<detailed_description>A prospective , non-randomized , multi-center , single-arm clinical trial evaluate safety efficacy RX HERCULINKâ„¢ 14 Peripheral Stent System treatment suboptimal post- procedural percutaneous transluminal angioplasty ( PTA ) result de novo restenotic atherosclerotic renal artery stenosis .</detailed_description>
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<criteria>Clinical diagnosis renal artery atherosclerosis ; candidate renal artery angioplasty stenting ; blood pressure &gt; 160/90 Totally occlude renal artery opposite side ; one functioning kidney ; target lesion transplant kidney ; renal insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>